Earlier this month, the US FDA and multiple EU drug inspection agencies released amendments to the Pharmaceutical Annex of the 1998 U.S.-EU Mutual Recognition Agreement. Under the new agreements, regulatory agencies are now able to use information gathered from mutual inspections, streamlining approval processes. Also included in the agreement are standardized approval procedures which eliminate miscommunication between agencies. This cooperation represents three years of collaboration n from both the United States and the European Union. Read the full article here.
